论文信息 - Phase I study of ACE-041, a novel inhibitor of vascular maturation, in patients with advanced solid tumors or relapsed/refractory multiple myeloma. - 字舞流文

Phase I study of ACE-041, a novel inhibitor of vascular maturation, in patients with advanced solid tumors or relapsed/refractory multiple myeloma.

H. Hurwitz | N. Solban | J. Bendell | M. Gordon | D. Mitchell | N. Borgstein | M. Sherman | C. Condon | S. Pearsall | Sanjay Sharma